Indexed keywords
METFORMIN;
SULFONYLUREA DERIVATIVE;
VEMURAFENIB;
DIABETES MELLITUS;
EDITORIAL;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
LIFESTYLE MODIFICATION;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OBESITY;
PATHOPHYSIOLOGY;
PERSONALIZED MEDICINE;
PHARMACOGENETICS;
PHENOTYPE;
PRIORITY JOURNAL;
COMPLICATION;
GENETICS;
LIFESTYLE;
MUTATION;
PROCEDURES;
RISK FACTOR;
DIABETES MELLITUS;
DIABETES MELLITUS, TYPE 2;
HUMANS;
LIFE STYLE;
MUTATION;
OBESITY;
PHARMACOGENETICS;
PRECISION MEDICINE;
RISK FACTORS;
1
85016613551
Dr. Karl Landstteiner Nobel Prize Laureate in Medicine, 1930
COI: 1:STN:280:DC%2BC3cvotFWisA%3D%3D, PID: 17839684
Bayne-Jones S (1931) Dr. Karl Landstteiner Nobel Prize Laureate in Medicine, 1930. Science 73:599–604
(1931)
Science
, vol.73
, pp. 599-604
Bayne-Jones, S.1
3
0016244025
Mild familial diabetes with dominant inheritance
Tattersall RB (1974) Mild familial diabetes with dominant inheritance. Q J Med 170:339–357
(1974)
Q J Med
, vol.170
, pp. 339-357
Tattersall, R.B.1
4
85016602912
Accessed 2 Mar 2017
Precision Medicine Catapult (2017) https://pm.catapult.org.uk/about-us/. Accessed 2 Mar 2017
(2017)
Precision Medicine Catapult
5
84969969745
Accessed 2 Mar 2017
National Institutes of Health (2016) www.nih.gov/news-events/news-releases/nih-awards-55-million-build-million-person-precision-medicine-study. Accessed 2 Mar 2017
(2016)
National Institutes of Health
6
34447559058
Accessed 2 Mar 2017
National Institutes of Health (2017a) https://ghr.nlm.nih.gov/primer/precisionmedicine/initiative. Accessed 2 Mar 2017
(2017)
National Institutes of Health
7
34447559058
Accessed 2 Mar 2017
National Institutes of Health (2017b) www.nih.gov/research-training/allofus-research-program. Accessed 2 Mar 2017
(2017)
National Institutes of Health
8
84868481873
Vemurafenib: the first drug approved for BRAF-mutant cancer
COI: 1:CAS:528:DC%2BC38XhsV2rsLjL, PID: 23060265
Bollag G, Tsai J, Zhang J et al (2012) Vemurafenib: the first drug approved for BRAF-mutant cancer. Nat Rev Drug Discov 11:873–886
(2012)
Nat Rev Drug Discov
, vol.11
, pp. 873-886
Bollag, G.1
Tsai, J.2
Zhang, J.3
9
85015632338
Precision diabetes: learning from monogenic diabetes
PID: 28314945
Hattersley AT, Patel KA (2017) Precision diabetes: learning from monogenic diabetes. Diabetologia. doi:10.1007/s00125-017-4226-2
(2017)
Diabetologia
Hattersley, A.T.1
Patel, K.A.2
10
85007174205
Genetics of obesity: can an old dog teach us new tricks?
Yeo GSH (2017) Genetics of obesity: can an old dog teach us new tricks? Diabetologia. doi:10.1007/s00125-016-4187-x
(2017)
Diabetologia
Yeo, G.S.H.1
11
85010734919
Lifestyle and precision diabetes medicine: will genomics help optimise the prediction, prevention and treatment of type 2 diabetes through lifestyle therapy?
Franks PW, Poveda A (2017) Lifestyle and precision diabetes medicine: will genomics help optimise the prediction, prevention and treatment of type 2 diabetes through lifestyle therapy? Diabetologia. doi:10.1007/s00125-017-4207-5
(2017)
Diabetologia
Franks, P.W.1
Poveda, A.2
12
85011845576
Painting a new picture of personalised medicine for diabetes
McCarthy MI (2017) Painting a new picture of personalised medicine for diabetes. Diabetologia. doi:10.1007/s00125-017-4210-x
(2017)
Diabetologia
McCarthy, M.I.1
13
85014781627
Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?
PID: 28283684
Florez JC (2017) Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool? Diabetologia. doi:10.1007/s00125-017-4227-1
(2017)
Diabetologia
Florez, J.C.1